Literature DB >> 20589745

Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells.

Patrick L Crittenden1, Nikolay M Filipov.   

Abstract

Multiple studies demonstrate that manganese (Mn) exposure potentiates inflammatory mediator output from activated glia; this increased output is associated with enhanced mitogen activated protein kinase (MAPK: p38, ERK and JNK) activity. We hypothesized that Mn activates MAPK by activating the kinases upstream of MAPK, i.e. MKK-3/6, MKK-1/2 and MKK-4 (responsible for activation of p38, ERK, and JNK, respectively), and/or by inhibiting a major phosphatase responsible for MAPK inactivation, MKP-1. Exposure of N9 microglia to Mn (250 µm), LPS (100 ng ml⁻¹) or Mn + LPS increased MKK-3/6 and MKK-4 activity at 1 h; the effect of Mn + LPS on MKK-4 activation was greater than the rest. At 4 h, Mn, LPS, and Mn + LPS increased MKK-3/6 and MKK-1/2 phosphorylation, whereas MKK-4 was activated only by Mn and Mn + LPS. Besides activating MKK-4 via Ser257/Thr261 phosphorylation, Mn (4 h) prevented MKK-4's phosphorylation on Ser80, which negatively regulates MKK-4 activity. Exposure to Mn or Mn + LPS (1 h) decreased both mRNA and protein expression of MKP-1, the negative MAPK regulator. In addition, we observed that at 4 h, but not at 1 h, a time point coinciding with increased MAPK activity, Mn + LPS markedly increased TNF-α, IL-6 and Cox-2 mRNA, suggesting a delayed effect. The fact that all three major groups of MKKs, MKK-1/2, MKK-3/6 and MKK-4, are activated by Mn suggests that Mn-induced activation of MAPK occurs via traditional mechanisms, which perhaps involve the MAPKs furthest upstream, MKKKs (MAP3Ks). In addition, for all MKKs, Mn-induced activation was persistent at least for 4 h, indicating a long-term effect.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20589745      PMCID: PMC2995008          DOI: 10.1002/jat.1552

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  55 in total

1.  Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells.

Authors:  Kumiko Tanabe; Rie Matsushima-Nishiwaki; Shinobu Yamaguchi; Hiroki Iida; Shuji Dohi; Osamu Kozawa
Journal:  J Neuroinflammation       Date:  2010-03-06       Impact factor: 8.322

2.  Monokine production by microglial cell clones.

Authors:  M Righi; L Mori; G De Libero; M Sironi; A Biondi; A Mantovani; S D Donini; P Ricciardi-Castagnoli
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

3.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta.

Authors:  S C Lee; W Liu; D W Dickson; C F Brosnan; J W Berman
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

4.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.

Authors:  J C Lee; J T Laydon; P C McDonnell; T F Gallagher; S Kumar; D Green; D McNulty; M J Blumenthal; J R Heys; S W Landvatter; J E Strickler; M M McLaughlin; I R Siemens; S M Fisher; G P Livi; J R White; J L Adams; P R Young
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

5.  Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.

Authors:  H Enslen; J Raingeaud; R J Davis
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

6.  Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate).

Authors:  G Meco; V Bonifati; N Vanacore; E Fabrizio
Journal:  Scand J Work Environ Health       Date:  1994-08       Impact factor: 5.024

7.  Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone.

Authors:  C C Chao; S Hu; K Close; C S Choi; T W Molitor; W J Novick; P K Peterson
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

Review 8.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

9.  Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.

Authors:  Ping Zhang; Kyle M Lokuta; Deanne E Turner; Bin Liu
Journal:  J Neurochem       Date:  2009-11-06       Impact factor: 5.372

10.  Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.

Authors:  B Dérijard; J Raingeaud; T Barrett; I H Wu; J Han; R J Ulevitch; R J Davis
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

View more
  12 in total

1.  Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output.

Authors:  Celia A Dodd; Nikolay M Filipov
Journal:  Neurotoxicology       Date:  2011-09-25       Impact factor: 4.294

Review 2.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease.

Authors:  Louise M Collins; Eric J Downer; André Toulouse; Yvonne M Nolan
Journal:  Mol Neurobiol       Date:  2014-06-24       Impact factor: 5.590

3.  Modulation of interferon-γ-induced glial cell activation by transforming growth factor β1: a role for STAT1 and MAPK pathways.

Authors:  Rodrigo Herrera-Molina; Betsi Flores; Juan A Orellana; Rommy von Bernhardi
Journal:  J Neurochem       Date:  2012-08-22       Impact factor: 5.372

Review 4.  Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework.

Authors:  Katherine von Stackelberg; Elizabeth Guzy; Tian Chu; Birgit Claus Henn
Journal:  Risk Anal       Date:  2015-06-10       Impact factor: 4.000

Review 5.  Inflammatory Activation of Microglia and Astrocytes in Manganese Neurotoxicity.

Authors:  Ronald B Tjalkens; Katriana A Popichak; Kelly A Kirkley
Journal:  Adv Neurobiol       Date:  2017

Review 6.  Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Miles R Bryan; Aaron B Bowman
Journal:  Adv Neurobiol       Date:  2017

7.  Neurotoxicity mechanisms of manganese in the central nervous system.

Authors:  Edward Pajarillo; Ivan Nyarko-Danquah; Getinet Adinew; Asha Rizor; Michael Aschner; Eunsook Lee
Journal:  Adv Neurotoxicol       Date:  2021-01-27

8.  In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function.

Authors:  Fabiano M Cordova; Aderbal S Aguiar; Tanara V Peres; Mark W Lopes; Filipe M Gonçalves; Aline P Remor; Samantha C Lopes; Célso Pilati; Alexandra S Latini; Rui D S Prediger; Keith M Erikson; Michael Aschner; Rodrigo B Leal
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

Review 9.  "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".

Authors:  Tanara V Peres; Maria Rosa C Schettinger; Pan Chen; Fabiano Carvalho; Daiana S Avila; Aaron B Bowman; Michael Aschner
Journal:  BMC Pharmacol Toxicol       Date:  2016-11-04       Impact factor: 2.483

10.  In vitro manganese exposure disrupts MAPK signaling pathways in striatal and hippocampal slices from immature rats.

Authors:  Tanara Vieira Peres; Daniela Zótico Pedro; Fabiano Mendes de Cordova; Mark William Lopes; Filipe Marques Gonçalves; Cláudia Beatriz Nedel Mendes-de-Aguiar; Roger Walz; Marcelo Farina; Michael Aschner; Rodrigo Bainy Leal
Journal:  Biomed Res Int       Date:  2013-11-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.